Last Price
0.119
Today's Change
+0.032 (36.78%)
Day's Change
0.085 - 0.214
Trading Volume
154,131,047
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Brian G. Atwood Mr. Brian G. Atwood
Full Time Employees: 8 8
IPO Date: 2021-11-30 2021-11-30
CIK: 0001870404 0001870404
ISIN: US71902K1051 US71902K1051
Beta: -0.44 -0.44
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.